Yahoo Finance

Operations: The company's revenue is primarily derived from its Healthy Food segment at €154.4 million and Healthy Ingredients segment at €110.5 million, with minimal contributions from Other Operations totaling €3.4 million.

Market Cap: €378.2M

Raisio plc, with a market cap of €378.20 million, offers a mixed outlook in the penny stock arena. While its short-term assets comfortably cover both short and long-term liabilities, indicating solid liquidity, recent earnings have declined by 8.4% annually over five years. The company's debt is well-managed with operating cash flow significantly exceeding it, and it holds more cash than total debt. However, its dividend yield of 5.86% isn't well covered by earnings. Raisio's recent guidance aims for €250 million in net sales by 2027 through organic growth and an EBIT target of over €30 million for the strategy period ending that year.

• Click here and access our complete financial health analysis report to understand the dynamics of Raisio.

• Review our growth performance report to gain insights into Raisio's future.

Uniphar

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Uniphar plc is a diversified healthcare services company operating in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally, with a market cap of €758.98 million.

Operations: The company's revenue is derived from three main segments: Pharma (€658.81 million), Medtech (€267.97 million), and Supply Chain & Retail (€1.84 billion).

Market Cap: €758.98M

Uniphar plc, with a market cap of €758.98 million, demonstrates mixed potential in the penny stock segment. The company reported strong revenue of €2.77 billion for 2024, supported by diverse segments including Pharma and Medtech. Earnings have shown robust growth with a 43.3% increase over the past year, surpassing industry averages; however, short-term liabilities exceed assets by €76.9 million, indicating liquidity concerns. Uniphar's debt is well covered by operating cash flow at 49.5%, yet its debt-to-equity ratio has risen to 62.4%. Recent initiatives include a share buyback program worth up to €35 million and increased dividends for shareholders.

• Unlock comprehensive insights into our analysis of Uniphar stock in this financial health report.

• Examine Uniphar's earnings growth report to understand how analysts expect it to perform.

Seize The Opportunity

• Jump into our full catalog of 433 European Penny Stocks here.

• Contemplating Other Strategies? Explore 21 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include HLSE:ILKKA2 HLSE:RAIVV and ISE:UPR.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com